Gilead Sciences, Inc. (GILD) Price Forecast — AI Targets | MarketCI

Gilead Sciences, Inc. (GILD) Price Forecast — AI Targets | MarketCI | MarketCI

GILD

Market Closed

Gilead Sciences, Inc.

NASDAQHealthcare Drug Manufacturers - General

17.60K employees

CEO: Daniel O'Day

Founded: 1992

$123.76

+$0.00(+NaN%)

Market Cap

153.66B

Beta

0.33

52W Range

N/A

Dividend Yield

2.60%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Forecasting Analysis

AI-powered predictions and statistical risk modeling for short-term price movements

AI Insight:

Gilead Sciences' AI short-term forecast shows marginal upside momentum, trending slightly higher. Analyst consensus reflects strong coverage with tight agreement, indicating broad alignment on 12-month upside potential. This consensus convergence suggests reduced uncertainty and clearer growth expectations.

Current Price

N/A

Last closing price

Price Prediction

Machine learning prediction based on historical price patterns

Period:

Analyst Price Target for GILD

Loading analyst price targets...

Wall Street Forecasts

Revenue Forecast

Past Growth

N/A

Based on Historical CAGR

Forward Growth

N/A

Projected CAGR

Analyst Accuracy

Estimate Accuracy

Revenue Analysis

Comparison of Actual and Estimated Revenues

Loading chart data...

Revenue growth steady at 0.0%.

Operating Profitability Forecast

Past Growth

N/A

EBITDA Historical CAGR

Forward Growth

N/A

EBITDA Projected CAGR

Analyst Accuracy

Estimate Accuracy

EBITDA Analysis

Comparison of Actual and Estimated EBITDA

Loading chart data...

EBITDA maintaining 0.0% trajectory.

Earnings Per Share Forecast

Past Growth

N/A

EPS Historical CAGR

Forward Growth

N/A

EPS Projected CAGR

Analyst Accuracy

Estimate Accuracy

EPS Analysis

Comparison of Actual and Estimated Earnings Per Share

Loading chart data...

EPS growth stable around 0.0%.

Explore GILD

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

GILD in the Healthcare

Large Cap

Healthcare

Browse sector stocks →

Drug Manufacturers - General

Browse industry stocks →